Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP502771.RAh0dLLYqBuCuouGpZm43_Q0KEDoi4fFNCZOqcQ0OI7-8130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP502771.RAh0dLLYqBuCuouGpZm43_Q0KEDoi4fFNCZOqcQ0OI7-8130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP502771.RAh0dLLYqBuCuouGpZm43_Q0KEDoi4fFNCZOqcQ0OI7-8130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP502771.RAh0dLLYqBuCuouGpZm43_Q0KEDoi4fFNCZOqcQ0OI7-8130_provenance.
- NP502771.RAh0dLLYqBuCuouGpZm43_Q0KEDoi4fFNCZOqcQ0OI7-8130_assertion description "[The authors conclude that a pVAX/PSA DNA vaccine can induce PSA-specific cellular immune responses in patients with hormone-refractory prostate cancer, thus emphasizing the potential for PSA as a target molecule for the immunotherapy of prostate cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP502771.RAh0dLLYqBuCuouGpZm43_Q0KEDoi4fFNCZOqcQ0OI7-8130_provenance.
- NP502771.RAh0dLLYqBuCuouGpZm43_Q0KEDoi4fFNCZOqcQ0OI7-8130_assertion evidence source_evidence_literature NP502771.RAh0dLLYqBuCuouGpZm43_Q0KEDoi4fFNCZOqcQ0OI7-8130_provenance.
- NP502771.RAh0dLLYqBuCuouGpZm43_Q0KEDoi4fFNCZOqcQ0OI7-8130_assertion SIO_000772 16000958 NP502771.RAh0dLLYqBuCuouGpZm43_Q0KEDoi4fFNCZOqcQ0OI7-8130_provenance.
- NP502771.RAh0dLLYqBuCuouGpZm43_Q0KEDoi4fFNCZOqcQ0OI7-8130_assertion wasDerivedFrom befree-2016 NP502771.RAh0dLLYqBuCuouGpZm43_Q0KEDoi4fFNCZOqcQ0OI7-8130_provenance.
- NP502771.RAh0dLLYqBuCuouGpZm43_Q0KEDoi4fFNCZOqcQ0OI7-8130_assertion wasGeneratedBy ECO_0000203 NP502771.RAh0dLLYqBuCuouGpZm43_Q0KEDoi4fFNCZOqcQ0OI7-8130_provenance.
- befree-2016 importedOn "2016-02-19" NP502771.RAh0dLLYqBuCuouGpZm43_Q0KEDoi4fFNCZOqcQ0OI7-8130_provenance.